Mount Sinai Rehabilitation Hospital
7
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Intermittent vs Continuous Walking in People With Multiple Sclerosis
Role: collaborator
Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?
Role: collaborator
Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis
Role: lead
Pilot Trial of Backwards Walking in Persons With Multiple Sclerosis
Role: lead
Lokomat Treadmill Training Effects on MS Gait
Role: lead
Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients
Role: lead
Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities
Role: lead
All 7 trials loaded